Considerable information now exists on the distribution of neurotensin (NT), an endogenous tridecapeptide in the mammalian central nervous system (CNS). The presence of high affinity binding sites for the peptide in the CNS, its depolarization-induced release and the alteration in neuronal firing rates after central application of the peptide all provide evidence of its role as a neurotransmitter or neuromodulator in the CNS. Much work conducted by our group, as well as by others, has demonstrated interactions of NT with CNS dopamine (DA) neurons. Neuroanatomical studies in which NT or NT binding sites have been localized have shown the presence of both the peptide and its receptors in proximity to or on DA neurons. In previous studies, we have demonstrated that centrally administered NT induces effects reminiscent of antipsychotic drugs. Thus, injection of NT into the nucleus accumbens, a major terminal site of the mesolimbic DA system, like antipsychotic drugs, blocks the effects of DA. Chronic antipsychotic drug treatment produces selective alterations in NT concentration in certain brain areas such as the neostriatum and nucleus accumbens. Previous studies have also shown reduced concentrations of NT in cerebrospinal fluid (CSF) of schizophrenic patients. In the present proposal we shall study in more detail the neurobiology of NT with particular emphasis on NT-DA interactions. The goals in our preclinical studies include: (1) elucidate NT-containing neural pathways in the rat brain, (2) determine whether high affinity NT binding sites are altered after destruction of NT pathways, (3) determine the effect of NT on DA-dependent and DA-independent phosphorylation in the rat CNS, (4) characterize in greater detail the effects of chronic antipsychotic drug treatment on NT-containing neurons in the CNS, (5) determine the effect of NT on DA autoreceptors, (6) determine the effect of NT on the supersensitivity induced by destruction of DA neurons, and (7) evaluate the effects of chronic NT administration on CNS DA systems. In our clinical studies we shall continue to assess the activity of NT-containing neurons by measurement of NT in CSF and post-mortem brain tissue of schizophrenic patients and measurement of high affinity NT receptors in post-mortem brain tissue. These studies of NT-DA interactions should provide novel findings relevant to the neurobiology of schizophrenia, as well as to the mechanism of action of antipsychotic drugs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37MH039415-10
Application #
3486692
Study Section
Special Emphasis Panel (NSS)
Project Start
1983-12-01
Project End
1994-12-31
Budget Start
1993-01-01
Budget End
1993-12-31
Support Year
10
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Emory University
Department
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Chastain, Lucy G; Qu, Hongyan; Bourke, Chase H et al. (2015) Striatal dopamine receptor plasticity in neurotensin deficient mice. Behav Brain Res 280:160-71
Cáceda, Ricardo; Binder, Elisabeth B; Kinkead, Becky et al. (2012) The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion. Schizophr Res 136:88-95
Flandreau, Elizabeth I; Ressler, Kerry J; Owens, Michael J et al. (2012) Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus. Psychoneuroendocrinology 37:27-38
Pariante, Carmine M; Nemeroff, Charles B (2012) Unipolar depression. Handb Clin Neurol 106:239-49
Martin, Elizabeth I; Ressler, Kerry J; Jasnow, Aaron M et al. (2010) A novel transgenic mouse for gene-targeting within cells that express corticotropin-releasing factor. Biol Psychiatry 67:1212-6
Gatt, Justine M; Williams, Leanne M; Schofield, Peter R et al. (2010) Impact of the HTR3A gene with early life trauma on emotional brain networks and depressed mood. Depress Anxiety 27:752-9
Gatt, Justine M; Nemeroff, Charles B; Schofield, Peter R et al. (2010) Early life stress combined with serotonin 3A receptor and brain-derived neurotrophic factor valine 66 to methionine genotypes impacts emotional brain and arousal correlates of risk for depression. Biol Psychiatry 68:818-24
Zeng, Fanxing; Mun, Jiyoung; Jarkas, Nachwa et al. (2009) Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter. J Med Chem 52:62-73
Stein, Dan J; Cloitre, Marylene; Nemeroff, Charles B et al. (2009) Cape Town consensus on posttraumatic stress disorder. CNS Spectr 14:52-8
Neigh, Gretchen N; Gillespie, Charles F; Nemeroff, Charles B (2009) The neurobiological toll of child abuse and neglect. Trauma Violence Abuse 10:389-410

Showing the most recent 10 out of 112 publications